ARMISTICE CAPITAL, LLC
CIK 1601086 · last filed 2023-06-28
ARMISTICE CAPITAL, LLC is a corporate insider who has filed 83 SEC Form 4 insider transactions across 15 companies since 2017. The most recent filing shows the insider sold $6.5M of AVTX on Jun 28, 2023. Across all open-market trades the lifetime net is +$140.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $233.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$233.31M
15
83
$140.94M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Director | 3,191 | $19.52 | $62.3K | -$1.94M | 6 | 2023-06-28 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 39,662,442 | $2.93 | $116.21M | $51.07M | 15 | 2021-08-06 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 48 | $15.68 | $753 | $0 | 1 | 2021-06-29 |
| EYEG | Director | 6,693,202 | $34.73 | $232.42M | $36.97M | 10 | 2021-01-08 |
| AYTU | Director | 133,334 | $2.13 | $284.0K | $24.00M | 1 | 2020-12-15 |
| TENX | Director | 2,519 | $15.80 | $39.8K | $277.6K | 2 | 2020-09-09 |
| Vaxart, Inc. (VXRT) Delisted | Director | 16,800,000 | $0.32 | $5.38M | -$1.57M | 1 | 2020-05-29 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 4,468,000 | — | — | $1.25M | 2 | 2020-03-18 |
| Traws Pharma, Inc. (ONTXW) Delisted | 10%+ Owner | 1,633,404 | $0.07 | $109.6K | -$39.0K | 1 | 2019-09-25 |
| ACHV | 10%+ Owner | 81,909 | $6.18 | $506.2K | -$404.5K | 1 | 2019-06-13 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | 10%+ Owner | 6,525,000 | — | — | $29.99M | 11 | 2019-06-06 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 2,116,000 | — | — | $465.8K | 4 | 2019-05-28 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 1,651,340 | — | — | -$2.02M | 1 | 2018-10-05 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 862,146 | — | — | $69.2K | 1 | 2018-06-22 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 32,440,000 | — | — | $2.82M | 8 | 2018-04-23 |
Recent Filings
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-28 | AVTX | Sell (S) | −11,050,626 | -$6.51M | EDGAR |
| 2023-02-09 | AVTX | Mixed | +1,351,002 | $4.0K | EDGAR |
| 2022-03-14 | AVTX | Buy (P) | +678,000 | $455.8K | EDGAR |
| 2022-01-20 | AVTX | Buy (P) | +936,000 | $823.5K | EDGAR |
| 2022-01-14 | AVTX | Buy (P) | +1,365,000 | $1.36M | EDGAR |
| 2022-01-11 | AVTX | Buy (P) | +1,935,000 | $1.93M | EDGAR |
| 2021-08-06 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +450,000 | $1.23M | EDGAR |
| 2021-06-29 | Vyome Holdings, Inc (RSLS) Delisted | Exer (X) | +14,261,612 | $0 | EDGAR |
| 2021-04-19 | Avalo Therapeutics, Inc. (CERC) Delisted | Conv (C) | +18,857,145 | $37.71M | EDGAR |
| 2021-01-12 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +7,500,000 | $19.50M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.